G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis

HOXB13 Mutation and Prostate Cancer: Studies of Siblings and Aggressive Disease

(2013) J. S. Witte et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

(2013) V. H. Laitinen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial

(2013) Z. Chen et al.   CARCINOGENESIS

The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

(2013) Wojciech Kluźniak et al.   PROSTATE

Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer

(2012) J. P. Breyer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HoxB3 promotes prostate cancer cell progression by transactivating CDCA3

(2012) Jing Chen et al.   CANCER LETTERS

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)

(2012) Jianfeng Xu et al.   HUMAN GENETICS

Association Between Germline HOXB13 G84E Mutation and Risk of Prostate Cancer

(2012) M. R. Akbari et al.   JNCI-Journal of the National Cancer Institute

Risk Factors and Prevention of Inguinal Hernia After Radical Prostatectomy: A Systematic Review and Meta-Analysis

(2012) Shimiao Zhu et al.   JOURNAL OF UROLOGY

A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer

(2012) Julius Gudmundsson et al.   NATURE GENETICS

Germline Mutations inHOXB13and Prostate-Cancer Risk

(2012) Charles M. Ewing et al.   NEW ENGLAND JOURNAL OF MEDICINE

A novel Germline mutation inHOXB13is associated with prostate cancer risk in Chinese men

(2012) Xiaoling Lin et al.   PROSTATE

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

(2011) Zsofia Kote-Jarai et al.   NATURE GENETICS

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE